These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21864526)

  • 1. Inhibition of advanced glycation end products by aminoguanidine restores mast cell numbers and reactivity in alloxan-diabetic rats.
    Carvalho VF; Florim LT; de O Barreto E; Torres RC; Batista MM; Amendoeira FC; Cordeiro RS; Martins MA; E Silva PM
    Eur J Pharmacol; 2011 Nov; 669(1-3):143-8. PubMed ID: 21864526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of PPARγ by restores mast cell numbers and reactivity in alloxan-diabetic rats by reducing the systemic glucocorticoid levels.
    Torres RC; Batista MM; Pons AH; Silva AR; Cordeiro RS; Martins MA; E Silva PM; Carvalho VF
    Eur J Pharmacol; 2012 Sep; 691(1-3):261-7. PubMed ID: 22713549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats.
    Soulis T; Cooper ME; Sastra S; Thallas V; Panagiotopoulos S; Bjerrum OJ; Jerums G
    Diabetologia; 1997 Oct; 40(10):1141-51. PubMed ID: 9349594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldose reductase inhibitor zopolrestat restores allergic hyporesponsiveness in alloxan-diabetic rats.
    Carvalho VF; Barreto EO; Serra MF; Cordeiro RS; Martins MA; Fortes ZB; e Silva PM
    Eur J Pharmacol; 2006 Nov; 549(1-3):173-8. PubMed ID: 16979157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoguanidine and the prevention of leukocyte dysfunction in diabetes mellitus: a direct vital microscopic study.
    Sannomiya P; Oliveira MA; Fortes ZB
    Br J Pharmacol; 1997 Nov; 122(5):894-8. PubMed ID: 9384505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of filamentous actin and apoptosis correlate with mast cell refractoriness under alloxan-evoked diabetes.
    Barreto EO; Carvalho VF; Oliveira MS; Bertho AL; Barja-Fidalgo TC; Cordeiro RS; Martins MA; e Silva PM
    Life Sci; 2006 Aug; 79(12):1194-202. PubMed ID: 16647092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
    Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes.
    Chang KC; Tseng CD; Wu MS; Liang JT; Tsai MS; Cho YL; Tseng YZ
    Eur J Clin Invest; 2006 Aug; 36(8):528-35. PubMed ID: 16893374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of allergic inflammatory response in the skin of alloxan-diabetic rats: relationship with reduced local mast cell numbers.
    de F Carvalho V; Campos LV; Farias-Filho FA; Florim LT; Barreto EO; Pirmez C; Savino W; Martins MA; e Silva PM
    Int Arch Allergy Immunol; 2008; 147(3):246-54. PubMed ID: 18594156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine.
    Roufail E; Soulis T; Boel E; Cooper ME; Rees S
    Diabetologia; 1998 Dec; 41(12):1419-25. PubMed ID: 9867208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.
    Gardiner TA; Anderson HR; Stitt AW
    J Pathol; 2003 Oct; 201(2):328-33. PubMed ID: 14517851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of RAGE in aminoguanidine-induced suppression of venous intimal hyperplasia in diabetic rats.
    Wang X; Diao Y; Zhang H; Huo X; Zhang Q
    Ann Vasc Surg; 2009 Mar; 23(2):246-54. PubMed ID: 19110400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats.
    Agardh E; Hultberg B; Agardh C
    Curr Eye Res; 2000 Jul; 21(1):543-9. PubMed ID: 11035534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of advanced glycation end-products prevent loss of enteric neuronal nitric oxide synthase in diabetic rats.
    Jeyabal PV; Kumar R; Gangula PR; Micci MA; Pasricha PJ
    Neurogastroenterol Motil; 2008 Mar; 20(3):253-61. PubMed ID: 17971026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
    Huang Y; Lin S; Zhou J
    Chin Med J (Engl); 1998 Aug; 111(8):698-704. PubMed ID: 11245022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graded sensitiveness of the various retinal neuron populations on the glyoxal-mediated formation of advanced glycation end products and ways of protection.
    Reber F; Geffarth R; Kasper M; Reichenbach A; Schleicher ED; Siegner A; Funk RH
    Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):213-25. PubMed ID: 12644946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of induced diabetes and the administration of aminoguanidine in the biomechanical retention of implants: a study in rats.
    Guimarães RP; de Oliveira PA; Oliveira AM
    J Periodontal Res; 2011 Dec; 46(6):691-6. PubMed ID: 21732947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical evidence for increased formation of advanced glycation end products and inhibition by aminoguanidine in diabetic rat lenses.
    Matsumoto K; Ikeda K; Horiuchi S; Zhao H; Abraham EC
    Biochem Biophys Res Commun; 1997 Dec; 241(2):352-4. PubMed ID: 9425275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes impairs hippocampal function via advanced glycation end product mediated new neuron generation in animals with diabetes-related depression.
    Wang SH; Sun ZL; Guo YJ; Yuan Y; Yang BQ
    Toxicol Sci; 2009 Sep; 111(1):72-9. PubMed ID: 19502549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotective effects of a novel inhibitor of advanced glycation.
    Forbes JM; Soulis T; Thallas V; Panagiotopoulos S; Long DM; Vasan S; Wagle D; Jerums G; Cooper ME
    Diabetologia; 2001 Jan; 44(1):108-14. PubMed ID: 11206401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.